Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 100 results in range #151 to #250.

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

  1. FMRI moc profile
  2. Fmri PubMed search
  3. Follow-up Editorial
  4. Fused Images
  5. Ground Truth Strategy
  6. Groundwork and Profiling
  7. Group 3A Call Summaries Archive
  8. Guidance Document Process
  9. How To's
  10. How to Create a Google Doc
  11. How to Upload Documents to the UPICT Library
  12. How to Write a Profile
  13. How to use QIBA Profiles
  14. I-123 Biomarker Committee
  15. ISMRM/QIBA PDFF Biomarker Ctte
  16. Industry
  17. Initial Target Selection
  18. Invitation to Participate
  19. Joe's test
  20. Johns Hopkins Univ School of Medicine
  21. Johns Hopkins University School of Medicine
  22. Johns Hopkins University School of Medicine, Round-2
  23. Julie's COPD archive
  24. Julie's test
  25. Julie's test page
  26. Lesion Sizing Toolkit
  27. List of Certified Conformant Users (QIBA Tested)
  28. List of Registered Conformant Users (Self-attestation
  29. List of Registered Conformant Users (Self-attestation)
  30. Lung Density/COPD BC Call Summaries Archive
  31. Lung Density BC Call Summaries
  32. Lung Density Biomarker Ctte
  33. Lung Nodule Assessment in CT Screening Call Summary Archive
  34. MRE BC Call Summaries Archive
  35. MRE Biomarker Committee Call Summaries
  36. MRE Biomarker Ctte
  37. MRE Profile
  38. MR Acquisition Protocols
  39. MR Archive
  40. MR Coordinating Committee
  41. MR Draft Proffered Protocols
  42. MR Elastography of the Liver, Clinically Feasible Profile
  43. MSK Biomarker Committee Call Summaries
  44. MSK Biomarker Committee Call Summaries Archive
  45. MSK Biomarker Ctte
  46. Main Page
  47. Maintenance Process
  48. Medical College of Wisconsin
  49. Metrology Committee
  50. Metrology Committee Call Summaries Archive
  51. Moc-up page
  52. Moc technical committee
  53. Modality Committee Archive
  54. Monthly FDG-PET Call Summaries
  55. Myocardial Blood Flow Biomarker Committee
  56. NIST
  57. NM Coordinating Committee
  58. New Protocol Here
  59. Normalization Process
  60. Orphan Documents
  61. PDFF Biomarker Committee Call Summaries
  62. PDFF Biomarker Committee Call Summaries Archive
  63. PDFF Biomarker Ctte
  64. PDF BC Call Summaries Archive
  65. PET Amyloid BC Call Summaries Archive
  66. PET Amyloid Biomarker Ctte
  67. PET Myocardial Blood Flow Biomarker Committee
  68. PET Myocardial Blood Flow Call Summaries
  69. PET Myocardial Blood Flow Call Summaries Archive
  70. PET Tau Biomarker Committee
  71. PUBLIC COMMENT WORK PAGE
  72. Perfusion, Diffusion and Flow-MRI Biomarker Ctte
  73. Perlman Advisory Group
  74. Phantom Development
  75. Phantom Development Subcommittee
  76. Phantom Development Technical Subcommittee
  77. Phantom Protocol & Data Analysis
  78. Phantoms And Tests Subcommittee
  79. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
  80. Pilot Conformance Projects Under Development
  81. Process
  82. Process Committee Agenda Archive
  83. Process Committee Call Summaries
  84. Process Committee Call Summaries Archive
  85. Process Coordinating Committee
  86. Process Education
  87. Proffered Protocols
  88. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting
  89. Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
  90. Profile: CT Lung Nodule Response
  91. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes
  92. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
  93. Profile: FDG-PET Whole Body
  94. Profile Conformance
  95. Profile Development
  96. Profile Editions
  97. Profile Strategy for Vol CT
  98. Profile drafts
  99. Profiles
  100. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)